stoxline Quote Chart Rank Option Currency Glossary
DarioHealth Corp. (DRIO)
1.2  0.03 (2.56%)    07-19 15:26
Open: 1.16
High: 1.25
Volume: 26,452
Pre. Close: 1.17
Low: 1.1546
Market Cap: 36(M)
Technical analysis
2024-07-19 2:50:44 PM
Short term     
Mid term     
Targets 6-month :  1.54 1-year :  1.77
Resists First :  1.32 Second :  1.51
Pivot price 1.25
Supports First :  1 Second :  0.83
MAs MA(5) :  1.28 MA(20) :  1.22
MA(100) :  1.45 MA(250) :  1.96
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  27 D(3) :  43.7
RSI RSI(14): 44.9
52-week High :  3.98 Low :  0.68
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ DRIO ] has closed above bottom band by 37.3%. Bollinger Bands are 23.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.26 - 1.27 1.27 - 1.28
Low: 1.13 - 1.14 1.14 - 1.15
Close: 1.16 - 1.17 1.17 - 1.18
Company Description

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Headline News

Thu, 18 Jul 2024
DarioHealth (NASDAQ:DRIO) Shares Cross Below 200 Day Moving Average of $1.62 - Defense World

Tue, 16 Jul 2024
Dario Expands GLP-1 Solution Client Base with New Employer Contract - StockTitan

Tue, 25 Jun 2024
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 - PR Newswire

Thu, 16 May 2024
DarioHealth Corp. (NASDAQ:DRIO) Q1 2024 Earnings Call Transcript - Insider Monkey

Wed, 15 May 2024
DarioHealth Reports First Quarter 2024 Financial and Operating Results - PR Newswire

Thu, 18 Apr 2024
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Diagnostics & Research
Shares Out 30 (M)
Shares Float 24 (M)
Held by Insiders 14.1 (%)
Held by Institutions 29.9 (%)
Shares Short 1,490 (K)
Shares Short P.Month 1,470 (K)
Stock Financials
EPS -1.68
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.65
Profit Margin -282.4 %
Operating Margin -310.1 %
Return on Assets (ttm) -31.4 %
Return on Equity (ttm) -71.7 %
Qtrly Rev. Growth -18.5 %
Gross Profit (p.s.) 0
Sales Per Share 0.63
EBITDA (p.s.) -1.89
Qtrly Earnings Growth 0 %
Operating Cash Flow -39 (M)
Levered Free Cash Flow -14 (M)
Stock Valuations
PE Ratio -0.72
PEG Ratio 0
Price to Book value 0.45
Price to Sales 1.88
Price to Cash Flow -0.93
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android